مباشر

Clinical OMICsPioneering Innovation in Transplant Diagnostics FierceBiotechRoche nabs EU approval on label expansions for companion dx platform FierceBiotechGenentech executes another round of layoffs, with 3 VPs axed ScienceLaser-boosted microscopes could reveal new drug targets, sharpen views inside cells ScienceThe ocean current that warms Europe may be more resilient than feared Clinical OMICsCyclana Bio Is Exploring the Extracellular Matrix to Treat Endometriosis FierceBiotechAI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data finds Clinical OMICsHigher Vitamin C Levels in Blood Linked to Healthier Aging Brains Clinical OMICsStopping Neurodegeneration in Place with Vaccines Clinical OMICsRemote Monitoring Benefits Unclear After Hospitalization for Serious Infection FierceBiotechNovo reports data breach, tells clinical trial patients to 'remain vigilant'Endpoints NewsThe seeming inevitability of rising healthcare costs

BioPharma Dive ١١ يونيو ٢٠٢٦

Sensorion, citing Regeneron competition, shifts focus to a different hearing loss therapy

A strategic review determined that the development environment had "notably changed," leading Sensorion to end work on its gene therapy for OTOF-related hearing...

A strategic review determined that the development environment had "notably changed," leading Sensorion to end work on its gene therapy for OTOF-related hearing loss.